New diet pill can block out fat
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The first of a new generation of anti-obesity drugs that work as fat blockers instead of appetite suppressants could be on the American market this year after US Government scientists recommended its approval.
The drug, Xenical, works by blocking the enzymes that digest fat which prevents it being absorbed from the gut. With the correct dose, a third of the fat eaten is blocked and excreted instead of ending up on the hips and thighs.
Traditional diet pills target the central nervous system and have an amphetamine-like action which suppresses the appetite. However, they can only be taken for limited periods and trials have shown that patients tend to regain weight lost when they stop using them.
Trials of Xenical, whose chemical name is orlistat, in 4000 patients in the US and Europe have shown it can cut about 600 calories a day. The average patient in the one year trial lost 10 kilos (more than 1.5 stones).
However, it is not a licence to gorge on cream cakes and burgers as the drug has unpleasant side effects . The presence of extra fat in the gut, which must be excreted, causes diarrhoea and a delicate condition known as "anal leakage" leading to "oily faecal spotting" which gets worse as more fat is consumed.
Although some patients dropped out of the trials because of the side effects, one of the most surprising findings was that others welcomed them because they provided a measure of biofeedback, indicating when they were eating too much fat.
On an average British diet containing 90 grams of fat a day, the drug prevents 30 grams being absorbed, equivalent to 270 calories.Doctors say a cut of a third in fat intake could reduce the incidence of heart disease and other disorders.
The drug's producer, Hoffman La Roche, has applied for a licence to the Medicines Control Agency in the UK and is awaiting approval from the Food and Drugs Administration in the US.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments